Acadia Pharmaceuticals Inc (ACAD)
San Diego, CA
Total Compensation for Fiscal Year Ending in 2024: $7,594,107
| Salary | $245,769 |
|---|---|
| Bonus | $196,721 |
| Value of Stock Awards | $3,321,364 |
| Value of Option Awards | $3,316,803 |
| Non-Equity Incentive Plan Compensation | $0 |
| Change in Pension Value and Deferred Compensation Earnings | $0 |
| All Other Compensation | $513,450 |
| Total | $7,594,107 |
Acadia Pharmaceuticals Inc disclosed its CEO pay was
25
times its median employee's pay for the fiscal year ending in 2024.
How Do You Compare?
